/ Side by side

BPC-157 vs TB-500

A neutral, side-by-side look at BPC-157 and TB-500: what each one is, its class, half-life, storage, and the public sources behind it. Educational reference only, not medical advice, dosing, or a recommendation to use either compound.

AttributeBPC-157TB-500
CategoryHealing / RecoveryHealing / Recovery
Half-lifeShort; ~15 minReported in hours; precise human PK sparse, subcutaneous
Common vial5, 10 mg5, 10 mg
ReferenceVerifiedVerified

What is BPC-157?

A synthetic pentadecapeptide (15 amino acids) derived from a gastric protein sequence, studied in animal models for angiogenesis and soft-tissue and gastrointestinal repair. Its effects appear to outlast its brief plasma presence.

Sources

  • Front Pharmacol 2022 (rat/dog PK)
  • Peer-reviewed angiogenesis reviews
Read the BPC-157 profile →

What is TB-500?

A synthetic peptide based on the active actin-binding region of thymosin beta-4, a G-actin-sequestering peptide studied for cell migration, angiogenesis and tissue repair.

Sources

  • Peer-reviewed thymosin beta-4 biology (TMSB4X)
Read the TB-500 profile →

Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.